Aptar Digital Health announces immuno-dermatology partnership with Legit.Health 

Aptar Digital Health announces immuno-dermatology partnership with Legit.Health 

Aptar Digital Health, a global expert in Software as a Medical Device (SaMD), digital Patient Support Programs (PSPs) and disease management solutions, has announced a new partnership with Legit.Health, an Artificial Intelligence (AI)-based medical device software company, which aims to transform patient care and increase patient adherence to better manage skin conditions. 

Legit.Health’s technology, which supports the diagnosis of approximately 300 conditions, including atopic dermatitis, psoriasis and skin cancer, will be integrated into Aptar’s Digital Health proprietary platform. This advanced digital solution will support healthcare professionals to diagnose skin conditions earlier and will enable patients to start sooner on treatment plans to improve their overall quality of life. The solution may also be used to facilitate patient enrolment in clinical trials. 

Legit.Health’s use of AI for monitoring disease progression through automated, clinically validated scoring systems will be leveraged within this partnership. This will help to ensure patients receive the most accurate and timely information to manage and treat their skin condition more effectively. 

Andy Aguilar, CEO and Co-founder of Legit.Health, said: “One of our main aims within the medical assistance process in the field of dermatology is to be able to offer patients the opportunity of having the earliest and most accurate diagnosis, with the appropriate referral and treatment to reduce uncertainty and waiting times.” She added, “Legit.Health’s technology helps the medical practitioner to provide this kind of care to their patients and today, thanks to our partnership with Aptar Digital Health, we will be able to reach even more people who will benefit from our service.” 

Click below to share this article